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ABSTRACT
Introduction:
                 Pancytopenia is a relatively common haematological entity. It is a striking
feature of many serious  and  life  threatening  illnesses  ranging  from  simple  drug
induced  bone  marrow  hypoplasia,  megaloblastic  marrow  to  fatal  bone  marrow
aplasias  and leukemias. The severity of pancytopenia and the underlying pathology
determines the management and prognosis. Thus, identification of the correct cause
will help in implementing appropriate therapy.
Objectives :
 To find out the incidence of pancytopenia in the clinical pathological setup.
 To find out the various causes of pancytopenia.
 To study the clinicopathological correlation
 To analyse the levels of vital hematological parameters during presentation.
Methods :
           This is a prospective study to evaluate patients with pancytopenia. 50 patients
of  age group between 2 to 60 years presenting with cytopenias were evaluated in 
Hematology unit, Department of Pathology, Coimbatore Medical College, Coimbatore 
during period of March 2010 to August 2011.Patients on myelotoxic chemotherapy were 
excluded.
Results :
        Among 50 cases studied, age of patients ranged from 5-60 years with a mean
age  of 39.5 years, and female predominance  M:F was 1:1.2. Most of the patients
presented  with generalised weakness and fever. Commonest physical finding was
pallor followed  by  hepatomegaly   and  splenomegaly. Dimorphic anaemia was
predominant  blood  picture. Bone marrow aspiration was conclusive in all cases.
Commonest marrow finding was hypercellularity with megaloblastic erythropoiesis.
The commonest cause for pancytopenia was megaloblastic anaemia (68%) followed
by aplastic anaemia (14%), myelofibrosis (12%),subleukemic leukemia (4%), 
myelodysplastic syndrome(2%).The commonest association was with Grade 2 
marrowfibrosis in reticulin stain.
Conclusion:
         Pancytopenia should be suspected on clinical grounds when a patient presents
with unexplained  anaemia, prolonged  fever  and tendency to bleed. Hence, present
study concludes that detailed primary haematological investigations along with bone
marrow aspiration in cytopenic patients is helpful for understanding disease process,
to diagnose or to rule out the causes of cytopenia. As a large proportion of pancytopenia 
is of reversible aetiology, early and accurate diagnosis may be life-saving.
Key words :
Pancytopenia; Megaloblastic anaemia; Bone marrow study.
INTRODUCTION
         Cytopenia is a disorder in which production of one or more blood cell types
ceases or is greatly reduced1.
         Pancytopenia is a disorder in which all three major formed elements of blood 
(red blood cells, white blood cells and platelets) are decreased than normal2.
          Manifestations of peripheral pancytopenia are due to a wide variety of 
disorders which primarily or secondarily affect the bone marrow7. The presenting 
symptoms are usually attributable to anaemia, thrombocytopenia and rarely 
leucopenia3 .
         Pancytopenia is a striking feature of many serious and life threatening illnesses 
ranging from simple drug induced bone marrow hypoplasia, megaloblastic marrow,
hypersplenism to fatal bone marrow aplasias and leukemias4.
        Varying factors encompassing geographic distribution, genetic factors, 
nutritional status  and the prevalence of infective disorder may cause variation in the
incidence of disorders causing pancytopenia 28.
         Careful assessment of the blood film is important if the reason for the 
pancytopenia is not apparent from the clinical history56. Physical findings and 
peripheral blood picture provide valuable information in the work up of pancytopenic 
patients and help in planning investigations on bone marrow samples5.
          Bone marrow evaluation is an invaluable diagnostic procedure in practice of
medicine which may confirm the diagnosis of suspected cytopenia, from the clinical 
features and peripheral blood examination or occasionally give a previously 
unsuspected diagnosis6.
         The severity of pancytopenia and the underlying pathology determine the
management and prognosis of these patients5.
           In India, the causes of pancytopenia are not well defined4. Previous studies
done in India, stress the importance of megaloblastic anaemia as being the major
cause of pancytopenia5,7.
           This study was carried out with an aim to obtain further information so that it 
would help in the management of patients with pancytopenia. Hence the present study 
has been undertaken to evaluate the various causes of pancytopenia and to correlate 
the peripheral blood findings with bone marrow aspirate and trephine biopsy.
          The extent of marrow fibrosis in relation to the underlying pathology was also 
assessed by reticulin silver stain in all cases57. The data obtained would help in 
planning the diagnostic and therapeutic approach in patients with pancytopenia.
AIM OF THE STUDY
             To assess the etiological profile of pancytopenia and do a correlation between
  the clinical presentation and  the various vital hematological parameters.
OBJECTIVES OF THE STUDY
 To find out the incidence of pancytopenia in the clinical pathological setup.
 To find out the various causes of pancytopenia.
 To study the clinicopathological correlation.
 To analyse the vital hematological parameters during presentation.
REVIEW OF LITERATURE
DEFINITION
Pancytopenia is defined as reduction of all the three formed elements of blood
below the normal reference range1.
HISTORY
Haemopoiesis, the production of blood cells is a fundamental concept in
hematology. The work of Neumann and Bizzozero established the relationship 
between blood and the bone marrow in eighteenth century. In 1868, Neumann noted 
that bone marrow was an important organ for the  formation of red blood 
cells2.Among the various causes of pancytopenia, literature regarding aplastic anemia 
and fanconi anemia alone are much available.
The earliest case description of aplastic anemia given, was by Dr.Paul Enrilch 
in  1888. He described a young woman who died following an abrupt illness that 
manifested as severe anemia,  bleeding, hyperpyrexia and a markedly hypocellular 
marrow3. In 1904, the term aplastic anaemia was introduced by Chaufford3 Aplastic 
anaemia, a disease due to the absence of haemopoiesis has had a parallel history since 
the discovery of the function of bone marrow in the midnineteenth century.
Familial syndrome of pancytopenia and congenital physical abnormalities was 
first reported in 1927 by Guido Fanconi . Fanconi described three brothers, who had 
pancytopenia as well as physical abnormalities; he called their macrocytic anaemia 
“perniziosiforme”1.   Naegeli suggested in 1931 that the term Fanconi anaemia be 
used for familial aplastic anaemia and congenital physical anomalies1.Pancytopenia 
due to nutritional causes and environmental influences were accounted only in the late 
20th century.
STUDIES ON PANCYTOPENIA
Various studies are available in literature, to delineate the causes of cytopenias 
as  manifestations of various systemic disorders .
Various studies throughout the world have reported aplastic anaemia  as  the 
commonest cause of pancytopenia4. The International Aplastic Anemia and 
Agranulocytosis Study(IAAAS) conducted a prospective study between 1980 and 
1984  in Europe and Israel which showed the overall incidence as 2 cases per 1 
million people ;however the incidence is 3 fold in southeast asia8.
Studies throughout India, revealed megaloblastic anaemia as the commonest 
cause of pancytopenia. A largest study in India conducted by Khunger et al which 
included 200 cases of pancytopenia concluded megaloblastic anemia as the 
commonest cause which accounted to 72%7.In anotherlong study carried out for 6 
years by Kumar et al of about 191cases megaloblastic anemia was detected in about 
39% of cases5.In a recent study by Thilak et al, megaloblastic anemia was proved to 
be the commonest cause and also revealed few interesting and rare causes of 
pancytopenia like drug induced agranulocytosis,waldenstroms macroglobulinemia 
etc4.
            By 1934, aplastic anaemia, although still not clearly defined, was described as 
a distinct clinical entity characterized by pancytopenia and thought to be the result of 
depressed bone marrow activity1. A study by  Khunger ,Morley A et al,  of  
lymphocytes from eleven patients with aplastic anaemia, suggested that in 7 patients  
the DNA was abnormal and ,it was hence concluded that in aplastic anaemia, DNA 
damage in stem cells may lead to a failure of proliferation7.   In the late 1960s , Mathe 
et al was among the first to postulate an autoimmune basis for aplastic anemia 9,10.
              Aplastic anemia being the most common cause of pancytopenia worldwide, 
many studies are available in the literature accounting for their etiology.   Idiopathic 
aplastic anaemia accounts for more than 70%cases of pediatric anaemia and it is 
imperative to search for an etiology in all cases of aplastic anaemia before they are 
labelled as idiopathic11.   
           Chloramphenicol, a broad spectrum antibiotic introduced in 1949 causes a dose 
dependent suppression of hemopoiesis, particularly erythropoesis, through its action 
on mitochondrial DNA12. Recovery from aplastic anaemia occurred four months after 
the discontinuation of suspected myelotoxic drugs and use of haematinics13.
        A child with hereditary spherocytosis who acquired human parvovirus B19 
infection developed transient pancytopenia14. Seronegative hepatitis precedes the 
diagnosis of aplastic anemia in 3 to 5% of cases and is recognized as hepatitis 
associated aplastic anemia15.
          A Leukemia Research Fund(LRF) -UK based study puts the annual incidence 
of MDS as 3.6 per 10000017 . One group has suggested a prevalance of 1 in 500 in 
those who presented with pancytopenia18. In a clinical study of primary 
myelodysplastic syndrome (MDS) in 33 children, it was noted that pancytopenia was 
the predominant presenting feature19. In a study of the haematological spectrum of 
myelodysplastic syndrome in 31 cases, pancytopenia constituted 16.1%20.           
  
             The bone marrow microenvironment played an important role in 
haematopoiesis by providing humoral factors and thus played a very pivotal role in 
arriving at  the diagnosis (Harigaya et al, 1981; Ohkawa & Harigaya, 1987; Sudo et 
al, 1989; Zhang et al, 2004).                     
Stromal microenvironment gave the clue for hematopoietic activity and, the 
stromal  collagen graded as reticulin has been proved over centuries(Weiss & Chen, 
1975; Watanabe, 1985; Cattoretti et al, 1993). Siegfried first used the term ‘reticulin’ 
in 1892.
CLINICAL FEATURES OF PANCYTOPENIA 
The onset of the disease is insidious, manifestations depending on  the severity 
of anaemia, leucopenia, and thrombocytopenia74.
Initial presenting symptoms include mild progressive weakness and fatigue
attributable to anaemia. Also patients are predisposed to various infections because of
neutropenia. Haemorrhage from skin, nose, and gums is due to thrombocytopenia.
Physical examination reveals fever, pallor, petechiae and ecchymotic patches
over the skin, mucous membranes  and conjunctiva74.
        Presence of splenomegaly and lymphadenopathy call for attention to the
possibility of leukemia, lymphoma, myelofibrosis and storage diseases.
On the other hand, lack of these signs as well as lack of evidence of vitamin 
B12 or folate deficiency should suggest multiple myeloma or aplastic anaemia.
Finally, rare presentations include diarrhea, jaundice and weight loss2.
HEMATOPOIESIS
       This is the process of production of the formed elements of the blood; there are 
cords, islands or clusters of precursor cells between the sinusoids, through whose 
endothelial cells the erythrocytes, leukocytes and platelets enter the blood stream3. 
The formed elements of blood – red cells, granulocytes, monocytes, platelets
and lymphocytes – have a common origin from pluripotent haematopoietic stem 
cells31.The pluripotent stem cell compartment gives rise to the stem cells for both 
myeloid and lymphoid lines, which in turn produce progenitor cells of progressively 
restricted potential3.
         From the common myeloid stem cell arise at least three types of committed stem 
cells capable of differentiating along the erythroid / megakaryocytic, eosinophilic and 
granulocyte-macrophage pathways24.  In addition stem cells give rise to mast cells, 
macrophages and osteoclasts, but not to the marrow fibroblasts and osteoblasts, whose 
origin  is in the mesenchyme26. 
           The only normal stromal components to be derived from the multipotential 
haemopoietic precursors are resident tissue macrophages27. 
           However, during embryonic development, a precursor cell can be identified 
which has the capacity to differentiate along either haemopoietic or angiogenic 
pathways. This cell, the haemangioblast is important in morphogenesis of embryonic 
vasculature as well as in haemopoiesis. It disappears as definitive haemopoiesis 
moves from structures, associated with the yolk sac to the liver; at this time, 
haemopoietic stem cells of adult type become predominant27.
      
ETIOLOGICAL CLASSIFICATION OF  PANCYTOPENIA 
        A wide range of disorders result in pancytopenia. For the sake of clarity,
aetiological factors have been divided into seven different groups3,21.
A) APLASTIC ANAEMIA 
1) FAMILIAL 
      a) Fanconi constitutional pancytopenia
      b) Shwachman – Diamond syndrome (pancreatic deficiency in children)
      c)Dyskeratosis Congenita
     d)Congenital Amegakaryocytic thrombocytopenia.
2) ACQUIRED22
      a) Idiopathic (autoimmune)
      b) Drugs 
 Analgesic
 Antiarrhythmic
 Anticonvulsants
 Antimicrobials
 Antimetabolites
 Alkylating agents
 Anticonvulsants
 Antithyroid
 Miscellaneous.
  c) Toxins
 Benzene
 Organophosphates
 Chlorinated hydrocarbons.
d) Viruses
 Ebstein –Barr Vrus
 Hepatitis
 HIV
e) Paroxysmal nocturnal hemoglobinuria
f) Autoimmune /Connective tissue disorders
g) Pregnancy 
h) Iatrogenic
B) DISORDERS INFILTRATING THE BONE MARROW 
 Hairy cell leukemia
 Agnogenic myeloid metaplasia
 Marble bone disease
 Osteopetrosis
 Aleukemic leukemia
 Multiple myeloma
 Metastatic carcinoma
 Myelofibrosis
 Myelosclerosis
C) DISORDERS INVOLVING THE SPLEEN 
 Hypersplenism 
 Lymphoma – Hodgkins and Non hodgkins
 Storage  disorders – Gaucher’s, Niemann Pick's disease
 Infectious diseases – Kala azar, Miliary tuberculosis, Syphilis
                                              Primary splenic panhematopenia.
D) VITAMIN B12 OR FOLATE DEFICIENCY 
 Pernicious anemia
 Malabsorbtion 
 Sprue
E) DISSEMINATED LUPUS ERYTHEMATOSUS
F) PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
G) MISCELLANEOUS DISORDERS (WITH CELLULAR MARROW) 
 Overwhelming infections
 Mycobacterial infection
 Alcohol    
 Brucellosis
 Sarcoidosis
 Some refractory anaemias
 Pregnancy (some cases)
 Sideroblastic anaemia (rarely)
PATHOPHYSIOLOGY OF PANCYTOPENIA 
Pancytopenia is the simultaneous presence of anaemia, leucopenia and 
thrombocytopenia and therefore it exists when there is a pathology which affects 
hematopoietic stem cells before they get differentiated 31.
Pancytopenia can be due to decrease in hemtaopoietic cell production in the 
bone marrow e.g. by infections, toxins, malignant cell infiltration or suppression or 
can have normocellular or even hypercellular marrow, without any abnormal cells, 
e.g. ineffective hematopoiesis and dysplasia, maturation arrest of all cell lines and 
peripheral sequestration of blood cells32. 
In other situations, however, the marrow may be normally cellular or even
hypercellular and no abnormal cells may be present. The mechanisms leading to 
pancytopenia in these conditions may be due to ineffective haemopoiesis with cell 
death in the marrow, formation of defective cells that are rapidly removed from the 
circulation, sequestration or destruction of cells by the action of antibodies, and 
trapping of normal cells in a hypertrophied and overactive reticuloendothelial 
system21.
APLASTIC ANAEMIA 
The word aplastic is derived from the Greek ‘a’ and ‘plasso’ meaning “without 
form”. Despite the potentially misleading term anaemia, patients with aplastic 
anaemia fail to form blood cells of all three lineages1.
        Potential mechanisms responsible for acquired marrow cell failure include22
  1) Direct toxicity to haemopoietic stem cell
  2) A defect in the stromal microenvironment of the marrow required for
       haemopoietic cell development.
  3) Impaired production or release of essential haemopoietic growth factors
  4) Cellular or humoral immune suppression of marrow progenitor cells.
So there are two major groups of bone marrow failure33
 The aplastic anaemias, in which the failure lies in the pluripotent stem cell.
 The single – cell cytopenias, in which the failure lies in one of the committed 
cell lines. However there is overlap between these two groups. 
Aplastic anaemia is defined by pancytopenia with a hypocellular bone marrow 
in the absence of an abnormal infiltrate and with no increase in reticulin34. Abnormal 
cells are not found in either the peripheral blood or in the marrow. The diagnosis is 
based on the absence of cells, not the presence of any characteristic feature33.
The diagnosis of aplastic anaemia requires at least two of the following in    
addition to a hypocellular marrow34
   i. Haemoglobin < 10 g/dl
   ii. Platelet count < 50× 109/L
   iii. Neutrophil count < 1.5 x 109 / L
The pathogenesis of aplastic anaemia remains unclear, but an autoimmune 
mechanism appears to be important. There may also be an as yet unidentified 
underlying genetic predisposition.  There is some association of HLA DR2, specially 
the DR15 split, with acquired aplastic anaemia33.  There is evidence of both 
quantitative and qualitative stem cell defect in aplastic anaemia and increased 
apoptosis of remaining early haemopoietic progenitor cells33. 
The sera  of patients with aplastic anaemia is examined in a short term liquid 
culture system of human bone marrow which permits CFU-C proliferation. When 
aplastic serum was added to adherent cell-depleted liquid cultures, the CFU-C 
stimulating property is lost, but increased megakaryopoiesis still occurs35. Not only do 
cytotoxic suppressor T lymphocyte release cytokines, such as interferon-γ and tumor 
necrosis factor α (TNF-α), that are inhibitory to haemopoietic progenitor cells but 
TNF-α also upregulates Fas antigen expression on CD34+ cells36.
Both lymphokine induced expression of the Fas receptor on CD34 progenitor 
cells; triggering of the Fas receptor  by its ligand initiates a fatal process of apoptosis. 
Apoptosis of hematopoietic cells in AA is suggested by the findings of high Fas 
receptor expression37.
                        
B) Aplastic anaemia secondary to drugs and physical agents               
1. Ionising Radiation
Ionizing radiation is directly toxic to the bone marrow stem/progenitor cells 
and high doses (>1.5Gy to the whole body) can lead to severe pancytopenia within 2 
to 4 weeks after exposure. LD50 has been estimated at about 4.5Gy ,and a dose of 
10Gy or greater is thought to have 100% mortality38. 
Large macromolecules such as DNA can be damaged directly by large 
amounts of radiant energy, which can rupture covalent bonds directly or indirectly by 
interaction with highly charged and reactive small molecule resulting from ionization 
of free radicals formed in solution1. Radiation –induced bone marrow failure is dose 
dependent and is a consequence of direct toxicity to stem and progenitor cells3.
2. Drug associated
Association between drug exposure and aplastic anemia can be divided into 
two classes. Cytotoxic drugs which causes dose dependent marrow suppression 
include acute cancer chemotherapy drugs and idiosyncratic drugs in which the 
occurrence of pancytopenia is unexpected and rare37. 
Chloramphenicol is the most notorious drug documented to cause Aplastic
Anaemia40. It is a prime example of  a drug that causes both dose related marrow 
suppression and idiosyncratic aplastic anaemia41. 
3. Chemicals
Benzene is a dangerous environmental contaminant found in organic solvents,
coal tar derivatives, and petroleum products1. 
The lipophilic properties of benzene , the constantly proliferative nature of red 
marrow ,and  the singular juxtaposition of the marrow stem cell compartments to the 
vast marrow fat depot suggest a rational hypothesis42.
              The hematologic effect of chronic poisoning of arsenic is pancytopenia and 
megaloblastoid dyserythropoiesis. This effect is attributed to inhibition of DNA 
synthesis, impaired absorption and utilization of folic acid43. 
C) Aplastic anemia secondary to infections
Acute infection with Epstein-Barr Virus (EBV) is often associated with 
peripheral blood cytopenia. Rarely acute EBV infection can be complicated by the 
development of aplastic  anaemia 44. Hepatitis associated aplastic anaemia is a variant 
of aplastic anaemia in which aplastic anaemia follows an acute attack of hepatitis45.  
The mechanisms of virus –induced acute marrow failure are highly diverse.They 
include selective invasion and lysis of erythroid precursors(pavoviruses),infection of 
stromal cells(cytomegaloviruses) and elicitation of cytotoxic immune 
response(Epstein-Barr Virus)46,47.  
Virus associated cytopenia can be directly due to infection and cytolysis of 
hematopoietic cells or indirectly through the elaboration of inhibitory cytokines and in 
some cases it may result from idiosyncratic immune response directed against stem 
cells3. 
  Direct infection of either stem cell or progenitor cells does not have significant 
role in marrow failure in AIDS patients42.
D) Pancytopenia associated with Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Haemoglobinuria (PNH) often develops in patients 
with aplastic anaemia. PNH clone was detected in the bone marrow of patients with 
aplastic anaemia and pancytopenia before affected cells were evident in the peripheral 
blood. Flow cytometry with monoclonal antibodies against decay accelerating 
factor(DAF) and CD59 were used for the detection of the clone48.PNH results from 
the expansion of an abnormal hematopoietic stem cells that harbors a somatic 
mutation of the X-linked gene PIGA .Small  to moderate PNH clones are found in up 
to 70% of patients with aplastic anemia.
Typically,<20% GPI-AP –deficient granulocytes are detected in aplastic 
anemia patients at diagnosis,but patients may also have larger clones40.  Aplastic 
anaemia and PNH are closely related syndromes49.
FANCONI ANAEMIA 
Fanconi anemia is an inherited chromosomal instability syndrome with a 
variable clinical presentation that includes congenital anomalies, progressive 
pancytopenia, and cancer susceptibility40 .
In vitro, the cells of patients with Fanconi anaemia grow slowly and resist cell 
division, accumulating in G2. The haemopoietic defect in Fanconi anemia is evident 
at the progenitor cell level40.  Fanconi anaemia is an inherited chromosomal instability 
syndrome with a variable clinical presentation that includes congenital 
anomalies,progressive pancytopenia, and cancer susceptibility50.
The diagnostic hallmark of FA is increased  chromosomal  breakage in 
response to DNA-damaging agents such as Mitomycin C (MMC) or Diepoxybutane 
(DEB)39. Physical anomalies and pancytopenia are not essential for diagnosis37,51.The 
chromosomal breakage test is usually performed on metaphase spreads of peripheral 
blood lymphocytes treated with MMC or DEB.A total of 50 cells in metaphase are 
analysed for chromosomal breakage ,including the formation of radicals-a hallmark of 
this disease52.
DYSKERATOSIS CONGENITA
Classic DC is an inherited disease characterized by the mucocutaneous triad of 
abnormal skin pigmentation ,nail dystrophy and mucosal leuoplakia54.
            In the inherited disorder Dyskeratosis Congenita, in which aplastic anaemia
usually develops in the second or third decade, the underlying genetic defects affect 
the telomerase complex, which has both RNA and protein components40.
In the X-linked form of the disease, a mutation is linked to Xq28 and the gene 
named DKCI, which codes for the protein dyskerin. In the autosomal dominant form, 
there is a Mutation found to reside in TERC gene and in few cases TERT that leads to 
a large deletion in telomerase RNA. Stem cells from patients with both types have 
markedly short telomeres3.
BLOOD FINDINGS OF APLASTIC ANEMIA 
  Patients with aplastic anemia have varying degrees of pancytopenia. The 
reticulocyte count usually is less than 1% and may be zero despite the high levels of 
erythropoietin . Macrocytes may be present. The total leukocyte count and platelet 
counts are low54. 
          The differential white cell count reveals a decrease in neutrophil and 
monocytes.  Thrombocytopenia usually develops initially, with subsequent onset of 
granulocytopenia and then anaemia54.
MARROW FINDINGS OF APLASTIC ANEMIA
Morphology
Both a bone marrow aspirate and trephine biopsy are required. Fragments 
should be readily obtained from the aspirate. The bone marrow is hypocellular with 
prominent fat and variable amounts of residual hematopoietic cells. Erythropoiesis is 
reduced or absent; dyserythropoiesis is very common and often marked34.
Megakaryocytes and granulocytic cells are reduced or absent; dysplastic 
megakaryocytes and granulocytic cells are not seen in aplastic anemia.  Lymphocytes, 
plasma cells, macrophages, and mast cells may be prominent, reflecting a lack of 
other cells rather than an increase in these elements54.
In the early stages of the disease, prominent hemophagocytosis by 
macrophages occurs as well as background eosinophilic staining representing 
interstitial edema is seen. The trephine is needed to assess overall cellularity, the 
morphology of residual hematopoietic cells and to exclude an abnormal infiltrate34. 
           The trephine is hypocellular throughout but is sometimes patchy with 
hypocellular and cellular areas. Reticulin is not increased and abnormal cells are not 
present34.
               In severe aplastic anemia, as defined by the International Aplastic Anemia 
Study Group, less than 25 percent cellularity or less than 50 percent cellularity with 
less than 30 percent haemopoietic cells is seen in the marrow79.
TABLE 1 : DEFINITION OF DISEASE SEVERITY OF APLASTIC
ANAEMIA (AA)56.Camitta criteria (camitta et al .1975)
SEVERE 
APLASTIC 
ANAEMIA
  BM cellularity <25% or
25-50% with <30% residual haemopoietic cells.
Two out of three of the following
Neutrophils <0.5 x 109/L
Platelets <20 x 109/L
Reticulocytes <20 x 109/L
    VERY 
SEVERE AA
As for severe AA but neutrophils <0.2 x 109/L.
NON 
SEVERE 
AA
Patients not fulfilling the criteria for severe or very severe AA with a
hypocellular marrow, with two out of three of the following;
Neutrophils <1.5 x 109/L, platelets < 100 x 109/L, haemoglobin
<10g/dL.
MEGALOBLASTIC ANAEMIA 
  Megaloblastic anemia is anemia that results from inhibition of DNA synthesis  
in red blood cell production. When DNA synthesis is impaired, the cell cycle  cannot 
progress from the G2 growth stage to the mitosis (M) stage. This leads to continuing 
cell growth without division, which presents as macrocytosis.
The defect in red cell DNA synthesis is most often due to hypovitaminosis, 
specifically a deficiency of vitamin B12 and/or folic acid.  The retarded DNA 
synthesis results in unbalanced cell growth. The RNA synthesis remains unimpaired, 
while cell division is restricted. Megaloblastic anemia not due to hypovitaminosis 
may be caused by antimetabolites that poison DNA production directly, such as some 
chemotherapeutic or antimicrobial agents. As a result, cytoplasmic contents, 
especially haemoglobin, are synthesized in excessive amounts during the delay 
between cell divisions. An enlarged cell is the end product of such a process57.
The morphlologic hallmark is nuclear-cytoplasmic dissociation which is best 
appreciated in precursor cells in the bone marrow aspirate. Megaloblastic nuclei are 
larger than normoblastic nuclei, and their chromatin appears abnormally dispersed 
due to its retarded condensation and hence termed as sieve like chromatin57.
Macro-ovalocytes are especially characterisic of megaloblastic anemia but are 
not specific. Eventually, poiklocytosis becomes more pronounced with tear drop cells, 
and nucleated red cells , Howell-Jolly bodies ,and even cabot rings appear in the 
blood in severe megaloblastosis. Leukopenia is present. Granulocytes have increased 
number of lobes. Thrombocytopenia is usually encountered and, on rare occasions, is 
sufficiently severe to be responsible for bleeding57.
          
MORPHOLOGY IN MEGALOBLASTIC ANEMIA58
PERIPHERAL SMEAR
 Increased mean corpuscular volume (MCV) with macroovalocytes (up to 
14µm)which is variably associated with anisocytosis and poikilocytosis.
 Nuclear hypersegmentation and polmorphonuclear neutrophils(PMN)(one 
PMN with 6 lobes or >5% with 5 lobes)
 Thrombocytopenia (mild to moderate)
 Leukoerythroblastic morphology(from extramedullary hematopoeisis)
BONE MARROW ASPIRATE
 General increase in cellularity of all three major hematopoietic elements.
 Abnormal erythropoiesis-orthonormoblastic megaloblasts
 Abnormal leukopoiesis - giant metamyelocytes, band forms(pathognomonic)
and hypersegmented PMNs.
Abnormal megakaryopoiesis – pseudohyperdiploidy
SUBLEUKEMIC LEUKEMIA 
The total white cell count in acute leukemia ranges between subnormal to
markedly elevated values. In about 25% of patients the total white cell count at the
onset is reduced ranging between 1-4 x 109/L59.
In subleukemic patients blast cells may be present in very small numbers in
peripheral blood. Buffy coat smear will help in detecting blasts under these
circumstances59.
         Peripheral smear shows anaemia with moderate anisopoikilocytosis. Neutrophils 
show hypogranulation and Pelger – Huet like anomaly. Immature white and red cells 
are absent or present only in small numbers at onset, but appear in the course of the 
illness. Blast cells predominate59.
         Bone marrow examination provides the diagnosis59.
MYELODYSPLASTIC SYNDROME (MDS)
         The myelodysplastic syndromes are a heterogeneous group of clonal stem cell 
disorders characterized by cytopenias due to impaired blood cell production, a 
hypercellular and dysplastic bone marrow, and an increased risk of leukemic 
transformation27.
        Pathology behind MDS is being explained on the basis of a stem cell disorder; 
Immunological abnormalities and apoptosis. The presence of trilineage dysplasia and 
cytogenetic abnormalities provides the evidence for a multipotent stem/progenitor cell 
origin. Immunological role is particularly apparent in cases of hypo plastic MDS 
those shares a number of features common with aplastic anemia notably clinical 
presentation with macrocytosis and varying level of dyserythropoiesis. The 
mechanism of cytopenia is being described on the basis of ineffective hematopoiesis 
and increased apoptosis58. Most cases undergo clonal evolution and transformation to 
acute myeloid Leukemia27. Clinical, haematological and histomorphological profile of 
MDS was studied in 37 cases. Primary MDS was seen in all age groups.The 
commonest presentation was Pallor and  the commonest subgroup was   Refractory 
Anaemia with Excess Blast (RAEB).
In low grade myelodysplasia (refractory anaemia and refractory anaemia with
ringed sideroblasts) the bone marrow usually shows varying degree of hyperplasia
with dyserythropoiesis. The granulocytic precursors and megakaryocytes do not
usually have morphological evidence of dysplasia27.
         These findings are relatively non-specific and can be seen in a variety of non-
neoplastic conditions such as vitamin B12 and folate deficiency or as a result of
chemotherapeutic agents. Thereby it is crucial to interpret the morphological feature 
in the light of all available clinical and haematological information27.
In high grade myelodysplasia, dyserythropoiesis is manifested principally by
alteration in the nucleus including budding, internuclear bridging, karyorrhexis,
multinuclearity, and megaloblastoid changes; cytoplasmic features including ringed 
sideroblasts, vacuolization, and PAS positivity, either diffuse or granular60.
Dysgranulopoiesis is characterized by small size, nuclear hypolobation
(pseudoPelger-Huet), and hypersegmentation, hypogranularity and pseudo Chediak-
Higashi granules60.   Megakaryocyte dysplasia is characterized by hypolobulated 
micromegakaryocyte, nonlobulated nuclei in megakaryocytes of all sizes, and 
multiple, widely separated nuclei60.
Trephine biopsies are more useful, the presence of small clusters or aggregates 
of myeloblasts and promyelocytes (5-8 cells) in marrow biopsies localized in the
central portion of the marrow away from the vascular structures and endosteal surface 
of the bone trabeculae in MDS is referred to as ALIP60.
The presence of three or more foci in a section is considered as ALIP positive,
and is frequently present in cases of RAEB and also indicates rapid evolution to acute 
leukemia60.
MYELOFIBROSIS
Primary marrow fibrosis is a clonal myeloproliferative neoplasm of the 
pluripotent haematopoietic stem cell in which the proliferation of multiple cell 
lineages is accompanied by progressive bone marrow fibrosis characterized by 
splenomegaly, leucoerythroblastic picture, bone marrow fibrosis and extramedullary 
haematopoiesis61.
In the early, so-called ‘cellular phase’ of CIMF, there may be little or no 
increase in bone marrow reticulin fibres. When an increase in bone marrow reticulin 
staining does occur, it is usually accompanied by an increase in bone marrow 
megakaryocytes, often morphologically atypical, as well as alterations in cellular and 
extracellular levels of cytokines with fibrogenic potential61.
The fibrosis in this disease is thought to represent a ‘reactive process mediated 
by cytokines that are  produced by the cellular components of the clonal proliferation’ 
(Tefferi, 2000). There is a stepwise evolution of the disease characterized by
prefibrotic and fibrotic stage62. 
Attempts at bone marrow aspiration often yields  a dry tap or a hemodilute 
sample and so bone marrow trephine biopsy is essential to make a diagnosis. Initial 
stages are characterized by an increase in the bone marrow cellularity in association 
with disorganization of marrow architecture and the presence of abnormal large 
megakaryocytes often occurring in clusters. Bone marrow fibrosis becomes 
increasingly dominant and progressively replaces hematopoeisis61.
Smears from successful aspirates may show no abnormality, but usually there
is neutrophilic and megakaryocytic hyperplasia. The megakaryocytes are often
morphologically abnormal. Micromegakaryocytes and macromegakaryocytes are
often observed, and there is nuclear – cytoplasmic asynchrony62.
Erythroid precursors may be normal or increased. Granulocytes may show
hyper or hypolobulation, acquired Pelger-Huet anomaly, and nucleo-cytoplasmic
asynchrony62.
Bone marrow biopsy is necessary to demonstrate fibrosis.Intrasinusoidal 
hematopoiesis can be seen at this stage. Histologically, late stages of fibrosis  can 
cause thickening of trabecula and extensive deposition of osteoid.  Increased number 
of mast cells may be observed in biopsy adjacent to fibrosis62. 
As the disease evolves, haemopoiesis frequently becomes ineffective and
blood cell counts fall leading to pancytopenia. Products of cells are released in the
marrow, including the platelet derived growth factor from megakaryocytes and
stimulate deposition of reticulin and fibrous tissue62. 
Diagnostic criteria  of myelofibrosis depends on the following factors ; 
Reticulin grade ≥3(on a 0-4scale), presence or absence of mutation in JAK2,palpable 
spleen, unexplained anemia,tear drop cells, leukoerythroblastic blood film,histological 
evidence of extramedullary hematopoeisis61.
TABLE 2 : MORPHOLOGICAL FINDINGS IN MYELOFIBROSIS62
MULTIPLE MYELOMA :
         It is a bone marrow based, multifocal plasma cell neoplasm characterized by a 
serum monoclonal protein and skeletal destruction with osteolytic lesions, 
pathological fractures, bone pain, hypercalcemia and anaemia63.
PREFIBROTIC STAGE FIBROTIC STAGE
BLOOD BLOOD
 No or mild    
leukoerythroblastosis.
 No or minimal RBC 
poiklocytosis.
 Few if any dacryocytes(Tear 
drop cells).
 Leukoerythroblastosis.
 Prominent RBC poiklocytosis with 
dacryocytes(Tear drop cells).
BONE MARROW BONE MARROW
 Hypercellular 
 Neutrophilic proliferation
 Megakaryocytic proliferation 
and atypia (clustering of 
megakaryocyte,abnormally 
lobulated megakaryocytic 
nuclei).
 Minimal or absent reticulin 
fibrosis.
 Reticulin and/or collagen fibrosis.
 Decreased cellularity.
 Dilated marrow sinuses with 
intraluminal haemopoiesis.
 Prominent megakaryocytic 
proliferation and atypia(clustering of 
megakaryocytes,abnormally lobulated 
megakaryocytic nuclei,naked 
megakaryocytic nulei).
 New bone formation (osteosclerosis).
         The myeloma cells may be morphologically fairly normal or may be moderately 
or severely dysplastic, common cytological features include marked pleomorphism, 
increased cell size, a high nucleo-cytoplasmic ratio, multinuclearity, nuclear 
lobulation, uniform cytoplasmic basophilia without a distinct golgi zone, presence of 
mitotic figures and cytoplasmic and nuclear inclusions63. 
       The cytoplasm of myeloma cells contain abundant endocytoplasmic 
reticulum,condensed or crystallized cytoplasmic immunoglobulin producing a variety 
of morphologically distinctive findings, including, multiple pale bluish – white grape
like accumulations (Mott cells, Morula cells), cherry red refractive round bodies
(Russell bodies), vermilion staining glycogen rich IgA (Flame cells) and crystalline
rods63.
       Peripheral smear in majority of patients shows anaemia, which is either
normocytic, normochromic or, less often, macrocytic. There is increased rouleaux
formation and increased background basophilic staining due to the presence of 
paraprotein  in the blood 63. 
        The blood film is occasionally leukoerythroblastic and it is often possible to find 
a small number of plasma cells or plasmacytoid lymphocytes63. 
        On biopsy ,it is characterized by an  excess of marrow plasma cells, seen in large
foci, nodules or sheets. In general, when 30% of the marrow volume is comprised of 
plasma cells, a diagnosis of plasma cell myeloma is considered. In histological
sections of marrow, the myeloma mass may occasionally be associated with 
prominent osteoclastic activity63.
Marrow destruction by tumor plasma cells results in anaemia, leucopenia and
Thrombocytopenia49. 
METASTATIC CARCINOMA 
       Patients with cancer frequently have anaemia, with or without other associated
cytopenias. Cancer related anaemia can be a direct result of tumor invasion of the
bone marrow, or indirect result of tumor therapy or systemic symptomatology, or an 
incidental finding resulting from other pathology in the patient64.
HYPERSPLENISM
           Hypersplenism is a clinical syndrome; it does not imply a specific causal
mechanism. It has the following characteristic features65.
1) Enlargement of spleen.
  2) Reduction in one or more of the cell lines in the peripheral blood.
  3) Normal or hyperplastic cellularity of the bone marrow, often with orderly
      maturation of earlier stages but paucity of more mature cells.
4) Premature release of cells in the peripheral blood, resulting in reticulocytosis
       and/or large immature platelets.
  5) Increased splenic red cell pool, decreased red cell survival and increased
        splenic pooling of platelets with shortening of their life span.
Some of the important causes of secondary hypersplenism are haematological
malignancies, storage disease, infections like malaria, typhoid, brucellosis,
leishmaniasis, collagen vascular diseases, congestive splenomegaly and splenic
tumors65.
MALARIA
           Italians in the 18th century named the disease ‘mal’ ‘aria’ meaning “foul air”51.
           It is a parasitic infection caused by obligate intracellular protozoa of the genus
Plasmodium51.Anaemia is the most prominent haematological manifestation of 
malarial infection. It is most marked with plasmodium falciparum species, which 
invades  erythrocytes of all ages. Cellular disruption and haemoglobin digestion lead 
directly to haemolysis66.
             An inadequate bone marrow response to anaemia is seen, with relative
reticulocytopenia. Leucocyte number may be slightly increased or normal, but
leucopenia as a result of splenomegaly and impaired marrow function is
characteristic. Thrombocytopenia is seen in nearly 70% of infections67.
          The bone marrow reactions caused by plasmodium vivax are qualitatively
similar to those caused by plasmodium falciparum not only in the red cell lineage but
also in other cell lines, characterized by dyserythropoiesis and ineffective
erythropoiesis68.
DISSEMINATED TUBERCULOSIS 
           Tuberculosis continues to be an important communicable disease in the world. 
The typical and varied spectrum of clinical presentation of tuberculosis poses a
diagnostic and therapeutic challenge to the physicians69. Various haematological 
presentations include normocytic normochromic anaemia, leucopenia, neutropenia, 
lymphocytopenia, monocytopenia, leucocytosis and monocytosis70.
             Pancytopenia is a rare haematological finding in disseminated tuberculosis 
and its degree is influenced more by the duration of infection than its severity71. 
Granulomas are found on bone marrow biopsy in 15-40% of patients with
disseminated tuberculosis.
         Acid fast bacilli cannot be demonstrated in most of the cases, and when seen
they are usually scanty. Presence of bone marrow plasmacytosis in patients with
tuberculosis is not uncommon72.
STORAGE DISEASES
               In various inherited diseases, the deficiency of an enzyme leads to
accumulation of a metabolite in body cells, often in macrophages. The 
morphologically abnormal bone marrow macrophages containing an excess of the 
relevant metabolite are referred to as storage cells58.
           Since splenic enlargement and marrow infiltration frequently lead to anemia , 
thrombocytopenia and leucopenia,  both  bone marrow aspirates and trephine biopsies 
are useful in the detection of storage diseases. Related abnormalities are noted in 
peripheral smears also58. 
Gaucher’s Disease
           It is an inherited condition in which glucocerebrosides accumulate in
macrophages including those in the liver, spleen and bone marrow73. 
         There are usually no specific peripheral blood features, although very
occasionally Gaucher’s cells may be seen in the peripheral blood, particularly after
splenectomy73. 
         Gaucher cells are large, round or oval cells with a small, usually eccentric
nucleus and voluminous weakly basophilic cytoplasm with a wrinkled  fibrillar or
onion-skin pattern73. 
Niemann-pick Disease : Inherited condition caused by reduced spingomyelinase
activity characterized by the presence of foamy lipid containing macrophages in the
bone marrow and other tissues73.  Anaemia and various cytopenias may occur as a 
consequence of Hypersplenism73.
ANATOMY OF BONE MARROW 
The term ‘bone marrow’ refers to the tissue occupying the cavities under the 
cortex within the honeycomb of trabecular bone23.  The bone marrow provides a 
unique microenvironment for the orderly proliferation, differentiation, and release of 
blood cells24.
             The hematopoietic tissue is localized in the extra vascular 
compartment.Erythropoietic islands and megakaryocytes are associated with the 
marrow sinusoids in the central regions of the marrow cavities,early myeloid 
precursors lie close to the endosteal surfaces,while the more mature forms of the 
granulocytic series are also found in the central intertrabecular areas23.
       Normal megakaryocytes lie next to sinusoids and extend cytoplasmic processes 
that bud off into the blood stream to produce platelets24.
          It is estimated that the weight of the marrow in an adult is 1500-3700g, about 
1000g of which is red marrow23. The marrow can undergo complete transformation in 
a few days and occasionally even in a few hours. The rapid transformation involving 
the whole organ as evidenced by the fact that a small sample represented by a biopsy 
or aspiration is usually fairly representative of the whole marrow25.
Bone marrow microenvironment
         The bone marrow stromal microenvironment is composed of  cells, structural 
fibrils   and extracellular matrix.  These elements provide a connective tissue structure 
for the bone marrow and physical support for the haematopoietic progenitor cells.. 
Bone marrow collagen is primarily composed of type I and type III collagen. 
           The term reticulin has been defined histochemically as the argyrophilic fibres 
identified by various silver staining methods.    Electron microscopic examinations 
reveals that reticulin is composed  mainly of individual fibrils or small bunches of 
fibrils of type III collagen surrounding a core of type I collagen fibrils, all embedded 
in a matrix of glycoproteins and glycosaminoglycans ( Fleischmajer et al, 1992; 
Fakoya, 2002; Ushiki, 2002).
CELLULARITY OF THE MARROW
         The marrow cellularity is expressed as the ratio of the volume of haemopoietic 
cells to the total volume of the marrow space (cells plus fat and other stromal 
elements)25.There are marked changes in the cellular composition of the marrow 
depending on the age of the subject and the site of aspiration28.
         Marrow cellularity is best judged by histological sections of biopsy or aspirated 
particles but should also be estimated from particles that are present in the marrow 
films25.  The myeloid / erythroid ratio is the ratio of total granulocytes to total
normoblasts. In new borns and infancy, it is somewhat higher than in later childhood 
or adult life. In adults, the range is broad, varying from about 1.5:1 to 3:125.
       The most reliable assessment of overall haemopoietic cellularity is based on the 
biopsy specimen.. Erythroid cellularity can be estimated visually by looking for 
erythroid aggregates which are clusters of darkly staining cells scattered throughout 
the marrow cavity. Adequacy of megakaryocyte numbers is also fairly readily evident 
at low power by the frequency of these large multilobulated cells29.
        Normocellular indicates about equal proportions or somewhat more 
hematopoiesis than fat cells. Hypocellular indicates reduction in hematopoiesis and a 
corresponding increase in fat cells. Variable marrow cellularity indicates 
intertrabecular spaces alternating with hyper or normocellular ones. Hypercellular is 
used when fat is decreased3. 
EVALUATION OF THE BIOPSY SPECIMENS 
  In a marrow smear regularly stained by Romanowsky method, the cell 
distribution and maturation abnormalities can be quite reliably determined. In addition 
to more reliable detection of the presence of lymphomas or metastatic tumor, the 
histologic pattern can often be diagnostic of the type of neoplasm30.
              In some conditions, such as myelofibrosis and hairy cell leukemia the bone 
marrow cannot be aspirated and biopsy is necessary to establish the diagnosis25.
          Trephine biopsy plays a vital role in histochemistry ,immunohistochemistry 
,cytogenetics ,biochemical and electron microscopic studies27.
DIAGNOSTIC APPROACH TO THE PANCYTOPENIC PATIENT2
                                         PANCYTOPENIA
                        
                                      History and examination
                               Blood film,retic count,
                                    Serum iron/TIBC
Palpable
Spleen with
Increase retic  Sepsis or       Blasts,
Count               bleeding      hyposegmented         Unexplained         
                                           or hypogranulated    spleenomegaly,M-   No specific    Hyper
                                              PMN’S                   protein or?mets      finding    segmented
                                                                                                                                PMN’S,        
                                                                                                                           markedaniso
                                                                                                                          poiklocytosis
                                                                                                                             
Investigate for
Hyperspleenism
Eg:CVC,chronic
Malaria.
                                                                                                       ?acid hemolysis   B12 
                                                                                                                                      folate
                                                                                                                Test                  
                                                                                                                                   No               
                                                                                                        ?HIV antibody  response  
                                                                                                                   test                       
                                                                                                                                response
                                                                                                                                       
                    Bonemarrow and aspiration and biopsy                                              Further
PMN=  Polymorhonuclear neutrophil,TIBC=total iron binding capacity,
            HIV=human immunodeficiency virus, CVC = Chronic venous congestion 
METHODOLOGY
          The present prospective study on “ Etiological Profile Of Pancytopenia-” was 
undertaken during the period of March 2010 to August 2011. Fifty  patients  from 
Government General Hospital  attached to Coimbatore Medical College , Coimbatore  
formed the material of the study . The study samples were analyzed in Haematology 
Unit, Department of Pathology, Coimbatore Medical College, Coimbatore. Patient 
selection was based on clinical features and supported by laboratory evidences.
        Bone marrow aspiration and trephine biopsy was subsequently carried out after 
obtaining written consent from the patient or the guardian.
Inclusion criteria 
Presence of three of the following
 Haemoglobin < 9 g/dl
 TLC <4000/cumm and
 Platelet count <1,00,000 / cumm
 Patients whose bone marrow had diagnostic aspirate 
Exclusion criteria :
 Patients on myelotoxic chemotherapy.
 Age <2years and >60 years. 
                   A proforma was used to document demographic data, clinical 
presentation, dietary history, past history of anaemia, blood transfusions and drugs 
and treatment history refractory to treatment as given in the annexure-1. Details of 
physical examination were obtained from medical records of patients. 
                  The study was conducted in a routine hematology laboratory at the same 
hospital. Three ml of blood sample was collected aseptically from each subject into 
tri-potassium ethylenediamine tetra-acetic acid (K3EDTA) anticoagulant bottle. This 
was thoroughly mixed  for complete blood count (CBC) analysis. Blood sample was 
divided into 2 parts as follows: Two  ml  for manual method and one  ml for 
automated method using hematology auto analyzer Sysmex KX-21. All manual 
samples were analyzed using standard hematological method as described by Dacie 
and Lewis [6]. All samples were analyzed within 30 minutes of collection.  
              
The laboratory tests performed were:
1. CBC using Sysmex KX-21 automated analyser and the analysis was done 
following the manufacturer's operational guidelines.
2. In cases of very low counts and abnormal cells, a manual review of the 
instrument’s   results was performed using the improved Neubauer counting 
chamber  using appropriate diluting fluids
      3.  A blood film was stained by the Leishman stain  and evaluated for red cell 
morphology, platelet count and white cell morphology .
      4.  Reticulocyte count using 1% Brilliant Cresyl Blue for supravital staining.
      5.  Peripheral smear and bone marrow aspiration smear  was stained by Leishman                                                  
             stain for all   the cases and examined in detail.
      6.  Bone marrow trephine biopsy was done for each case,then proceeded with 
fixation, partial decalcification and stained with H&E.
       7.   Added to it reticulin stain was done and the extent of fibrosis was graded.
AUTOANALYSER39
PRINCIPLE
          The hematological parameters were obtained from EDTA blood sample 
analyzed using SYSMEX –KX 21 autoanalyser. The principles of autoanlyser is as 
follows:
             Principles of this analyser includes electric impedence, light scattering and 
radiofrequency conductivity.  : This method detects the size of the blood cells by 
changes in direct-current resistance, and the density of the blood cell interior by 
changes in radio-frequency resistance. A blood sample is aspirated and measured, 
diluted to the specified ratio, and send to the applicable detector chamber. Inside the 
chamber is a tint hole called an “aperture,” on both sides of which are electrodes.
Between the electrodes flow the direct current and radio-frequency current. 
          Blood cells suspended in the diluted sample pass through the aperture, changing 
the direct-current resistance and radio-frequency resistance between the electrodes. 
The size of the blood cell is detected via changes in the direct-current resistance, and 
the density of the blood cell interior (size of the nucleus) is detected via changes in the 
radio frequency resistance, with such detections coming in the form of electrical 
pulses. Based on the size of these pulses, a two dimensional distribution (scatter 
gram) of the blood-cell size and internal density can be drawn.
                 
Samples were analysed in autoanalyser and the values of 18 parameters was 
obtained in the printed format as given in annexure 3 table - (3).
PERIPHERAL SMEAR
                   From the available venous sample a tongue shaped peripheral smear was 
made in a glass slide. Following air drying smear was stained with leishmans stain as 
follows :
LEISHMANS STAIN
1. Slide is exposed to undiluted stain solution for 2min.
2. Without removing the stain from the horizontal slide, double the  amount of buffer 
is carefully  added ,and mixed by blowing gently and allowed for staining for 8-
10mins. 
3. The stain is flushed from the horizontal side with water but not more than 30secs.
4. The back of the slide is cleaned with gauze and allowed to air dry.
Examination of blood smear
    Each blood smear is examined for adequacy, morphology and any immature forms 
in red cells, white cells and platelets. Thorough  examination for the presence of any 
hemoparasites was also done.
Reticulocyte count 
A small amount of 1% briliant cresyl blue stain was filtered into a test tube. 
Two drops of the filtrate and two drops of well-mixed blood specimen was transferred 
into a small test tube with the help of two separate Pasteur pipettes. New methylene 
blue stain and the blood specimen were mixed and the test tube was covered with a 
cork to prevent evaporation. The test tube was left undisturbed for 15 minutes at 
37 0C.
After 15 minutes the contents of the tube were removed and one small drop of 
the mixture was transferred to a clean grease-free slide. A thin smear was prepared 
with the help of a spreader slide. Smear was air dried. The smear was first examined 
under the low power objective for scanning and a thin portion of the smear where the 
red cells were evenly distributed was located. Reticulocytes were identified by the 
fine, deep violet filaments arranged in a network and fine dot like structure.
              The slide is examined under the microscope using the oil immersion 
objective. To decrease the eye field a small circular piece of black paper in the centre 
of which has been cut a small sqaure with sides of about 4 mm in length was inserted 
into the eyepiece. A total of 1000 red blood cells were counted using the oil 
immersion field and during the count, number of reticulocytes were noted and the 
percentage was calculated using the formula
            Reticulocyte count(%)=Number of reticulocytes counted ×100
                                                     Number of red cells counted
            Normal value → 0.5 – 2.5% (reference Dacie & Lewis) 
BONE MARROW ASPIRATION 
         Bone marrow aspiration was performed in all the patients using Salah needle
after obtaining written consent for the procedure either from the patient or the 
guardian. The aspiration site was prepared, cleaned with an antiseptic (spirit and 
betadine), scrubbed and draped, exposing only the aspiration site. Skin and the area 
down to the periosteum was infiltrated with 2 ml of local anaesthetic (2% lignocaine) 
using 5 ml syringe.
       The needle with the stylet in place was introduced into the site by gentle 
screwing motion, after adjusting the guard to appropriate length. The outer plate of 
bone was pierced with a gentle boring motion. As the marrow cavity was entered, 
sensation of giving in was experienced. Then the stylet was removed, and 0.2 ml of 
marrow material was aspirated with the help of 10 ml disposable syringe.
The aspirate was transferred to a set of slides and films were prepared by 
crushing the marrow particles. The needle was withdrawn and the puncture site was 
sealed with tincture benzoin swab. In cases of unsuccessful attempts of bone marrow 
aspiration, a repeat aspirate was done at the different site and only cases where 
diagnostic aspirate could be obtained have been included in the study.
Slides were dried and later stained with Leishman stain and marrow aspiration 
smears were examined for
i) Cellularity                    v) Megakaryopoiesis 
ii) M:E ratio                    vi) Others – plasma cells, lymphocytes, mast cells
iii) Erythropoiesis           vii) Parasites
iv) Myelopoiesis             viii) Abnormal cells
(Comparative normal ranges of BM – DC is given in annexure 3 table -2) 
BONE MARROW TREPHINE BIOPSY
       Following aspiration, bone marrow biopsy is done in the same site using the 
Jamshidi needle and its immediately fixed in 10% formalin. The biopsy is processed 
to obtain paraffin wax blocks. Less than 4µm thick sections are cut and stained with 
hematoxylin and eosin stain and reticulin. 
Stained slides were examined for the following:
I. Cellularity of bone marrow.
II. Bone marrow architecture.
III. Bone structure.
IV. Focal lesions
V. Marrow fibrosis analysed using Reticulin stain.
RETICULIN STAIN
            Bone marrow biopsy sections can be stained for reticulin using a silver 
impregnation technique, such as Gomori’s stain  that probably identifies the 
glycoprotein matrix in which the collagen fibrils lie, rather than the collagen fibrils 
themselves. 
           The reticulin stain is based on the high content of hexose sugars in reticulin.
Reticulin fibres have little natural affinity for silver solutions and must be pretreated 
to produce sensitized sites where silver will deposit.
1) Deparaffinize sections and bring to water.
2) Treat with 1%potassium permanganate solution -1min (the adjacent hydroxyl 
groups of the hexose sugars of glycoproteins are oxidized to aldehydes by 
potassium permanganate.)
3) Rinsed in tap water.
4) Bleached in 2%potassium metabisulfate solution-1 min,then rinsed in tap 
water.
5) Sensitized with ferric ammonium sulphate – 1 min and washed in distilled 
water.
6) Impregnated in silver solution (containing silver nitrate , KOH, and ammonia) 
for 1 min.
7) Washed in distilled water several times.
8) Reduced in 20% formalin solution for 3 minutes (local silver reaction is 
amplified to produce visible silver deposits). Then rinsed in tap water.
9) Toned in 0.2 % gold chloride for 10 minutes. Rinsed again in tap water.
10) Treated with 2 % potassium metabisulfite solution for 1 min. Rinsed again in 
tap water.
11) Treated with 2 % sodium thiosulfate solution for 1 min . Rinsed again in tap 
water.
12) The section is typically counterstained with eosin so the defined  reticulin 
fibres appear black against a background of red tissue
           Ideally, both a trichrome collagen stain and a reticulin stain should be 
performed and both the type and amount of fibrosis should be described using a 
clearly defined grading scale; however, in practice, collagen is almost never revealed 
by trichrome stain unless there is a marked increase in reticulin.
          Grading of fibrosis was done using the Bauermister scale as 0-4.
Quantification of bone marrow reticulin and collagen (Bauermeister, 1971; Bain et 
al, 2001)
Modified Bauermeister scale 
Grades Morphology
0 No reticulin fibres demonstrable
1 Occasional fine individual fibres and foci of a fine fibre network
2 Fine fibre network throughout most of the section; no coarse fibres
3
Diffuse fibre network with scattered thick coarse fibres but no mature collagen  
(negative trichrome staining)
4 Diffuse, often coarse fibre network with areas of collagenization (positive       
trichrome  staining)
                               
OBSERVATION AND RESULTS
               Out of 4370   cases enrolled in the Inpatient section of Hematology Unit in
the Department of Pathology, Coimbatore Medical College and Hospital patients who 
presented with pancytopenia were analysed.A total of 50 cases were enrolled as per 
inclusion and exclusion criteria.
TABLE 3
PROCEDURE CARRIED OUT IN 50 PATIENTS
Sl.No.                    Procedure 
No. of 
patients
1 Baseline haematological procedure 50
2 Bone marrow aspiration 50
3 Bone marrow trephine 50
4 Reticulin stain 50
In the present study 50 patients were taken for the study of Baseline haematological 
procedure, Bone marrow aspiration, Bone marrow trephine and Reticulin stain (chart-1). 
TABLE 4
DISTRIBUTION OF VARIOUS CAUSES OF PANCYTOPENIA
Sl. No                  Causes No. of cases Percentage
1 Megaloblastic anemia 34 68
2 Aplastic anemia 7 14
3 Myelofibrosis 6 12
4 Subleukemic leukemia 2 4
5 Myelodysplastic syndrome 1 2
Total 
50 100
In the present study, Megaloblastic anemia was the commonest cause constituting  
68% followed by  Aplastic anemia (14%), Myelofibrosis (12%), Subleukemic leukemia (4%) 
and  Myelodysplastic syndrome (2%) (chart-2).
TABLE 5
INCIDENCE OF PANCYTOPENIA IN DIFFERENT AGE GROUPS
Sl. No. Age group 
(years)
No. of cases Percentage
1 2-10 3 6
2 11-20 5 10
3 21-30 9 18
4 31-40 4 8
5 41-50 15 30
6 51-60 14 28
Total 50 100
In the above age groups frequency table, it is observed that the incidence of 
pancytopenia is high ( 30%) in the age group of 41-50 followed by the age group of  51-60 
(28%), 21-30 (18%), 11-20 (10%), 31-40 (8%) and 2-10 (6%) (chart-3).
TABLE 6
INCIDENCE OF PANCYTOPENIA IN DIFFERENT SEX GROUPS
Sl. No Sex No. of cases Percentage
1 Male 23 46
2 Female 27 54
Total 50 100
              From the above table, it is seen that the incidence of pancytopenia is 
comparatively high in women than men (chart-4). 
TABLE 7
AGE-WISE AND SEX-WISE DISTRIBUTION AMONG 50 PATIENTS,
UNDER THE PRESENT STUDY
Sl.no.
Age 
group 
(years)
Females Males Total Percentage 
1 2-10 3 0 3 6
2 11-20 4 1 5 10
3 21-30 4 5 9 18
4 31-40 2 2 4 8
5 41-50 7 8 15 30
6 51-60 7 7 14 28
TOTAL 27 23 50 100
The average age of the women is  35 .5 years ,and the men  is 39yrs   with the 
standard deviation17.44    and  13.56 respectively . The coefficient of variation for the 
females is  49.11   while for the males is 34.79  . From this, it is evident that there is a vast 
variation in the age  group of females (chart-5). 
TABLE 8
PRESENTING COMPLAINTS AND PHYSICAL FINDINGS IN
PANCYTOPENIA
Sl.no. Presenting complaints &physical 
findings
No .of 
.patients
Percentage 
1 Generalized weakness 50 100
2 Dyspnoea 23 46
3 Fever 23 46
4 Bleeding manifestation 1 2
5 Weight loss 5 10
6 Pallor 43 86
7 Splenomegaly 18 36
8 Hepatomegaly 20 40
9 Jaundice 4 8
10 Bony tenderness 1 2
11 Lymphadenopathy 1 2
For this study of pancytopenia, various physical complaints and findings were 
taken into account. All the patients were affected by the generalized weakness. Nearly 
46%  of the them had Dyspnoea and Fever ,nearly 86% of the cases had Pallor; 40% 
cases had hepatomegaly, 36% had splenomegaly, 10% of the cases had weight loss, 
8% had jaundice and 2% had bony tenderness, lymphadenopathy and bleeding 
manifestations,each(chart-6).
TABLE 9
VITAL HAEMATOLOGICAL PARAMETERS IN CASES OF
PANCYTOPENIA
Hemoglobin percentage:
Hemoglobin percentage varied from 1.8 % - 9.0g %. Most of the patients had 
Hemoglobin percentage between 5.1 – 8g %. While 40 % had Hemoglobin percentage 
between 1.8 – 5g %, 12 % had Hemoglobin percentage between 8.1 – 9.0g %.
Total leukocyte count:
Total leukocyte count ranged from 500 – 3,900 cells/mm3 . Almost  two-third 
of the patients ( 66% ) had leukocyte count in the range 2,501 – 3,900 cells/mm3. 
Only 6 % of the patients had white cell count in the range of 500 – 1,000 cells/mm3.
Reticulocyte count:
Reticulocyte count ranged from 0.5 – 2 %. Almost half of the patients ( 48 % ) 
had reticulocyte count between 0.6 – 1 %. Among the remaining 52 % of the patients, 
half of them ( 26 % )  had the reticulocyte count< 0.5% and the remaining 26 %  of 
the patients had reticulocyte count in the range 1.1 – 2%. 
Sl.no Parameter Range No .of. cases Percentage 
1 Hemoglobin(gm%)
1.8-5 20 40
5.1-8 24 48
8.1-9.0 6 12
Total 50
2
Total leukocyte 
Count (cells/mm3) 
500-1,000 3 6
1,001-2,500 14 28
2,501-3,900 33 66
Total 50
3
Reticulocyte 
Count(%)
<0.5 13 26
0.6-1 24 48
1.1-2 13 26
Total 50
4
Platelet  count 
(cells/mm3)
10,000-50,000 22 44
51,000-80,000 25 50
81,000-95,000 3 6
                                           Total 50
Platelet  count:
Platelet  count varied from 10,000 – 95,000 cells/mm3. While 50 % of the 
patients had their Platelet  count in the range 51,000 – 80,000 cells/mm3, another 44 
% of the patients had their Platelet  count in the range 10,000 – 50,000 cells/mm3. 
Only 6 % of the patients had platelets count in the range of 81,000 – 95,000 (chart-7).
TABLE 10
PERIPHERAL BLOOD PICTURE IN PANCYTOPENIC PATIENTS
Sl.No.                    Procedure 
No. of 
patients
Percentage
1
Dimorphic anaemia 
23 46
2
Macrocytic anaemia  
12 24
3
Normocytic normochromic
10 20
4
Normocytic hypochromic
5 10
Total 50 100
In the present study of 50 patients pancytopenia, the incidence of Dimorphic 
anaemia was higher (46%) than Macrocytic anaemia  (24%), Normocytic normochromic  
anemia(20%) and Normocytic hypochromic anemia(8%) (chart-8).
TABLE 11
CELLULARITY OF BONE MARROW
Sl.no Type of cellularity No.of patients Percentage
1 Hypercellularity 38 76
2 Hypocellularity 11 22
3 Normocellularity 1 2
Total 50 100
In the present study, Hypercellularity is the commonest association constituting 
78% followed by Hypocellularity (20%) and  Normocellularity (2%) (chart-9).
TABLE 12
CAUSES OF HYPERCELLULAR BONE MARROW ASSOCIATED WITH
PANCYTOPENIA
sl.no Aetiology No.of cases Percentage
1
Megaloblastic anemia 33
87
2
Sub leukemic leukemia 2
5
3
Cellular phase of MF 2
5
3
MDS 1
3
Total 38 100
In the present study ,out of the 40 patients with hypercellular bone marrow,
Megaloblastic anemia was observed in 87%, Cellular phase of MF in 5%, Sub 
leukemic leukemia in 5% and MDS in 3% (chart-10).
TABLE 13
INCIDENCE OF MEGALOBLASTIC ANAEMIA IN DIFFERENT AGE
GROUPS
Sl. No. Age group (years) No. of cases Percentage
1 2-10 2 6
2 11-20 3 9
3 21-30 8 23.5
4 31-40 2 6
5 41-50 11 32
6 51-60 8 23.5
Total 34 100
Age incidence:
               Megaloblastic anemia showed highest incidence (32%) in the age group of 41-
50years  , equal incidence (23.5%) in age groups of 21-30years and 51-60years followed by 
9% in 11-20years,6% in the age group of 2-10years and 31-40years respectively (chart-11). 
Figures 5&6 depicts the bone marrow picture of magaloblastics anemia. 
TABLE 14
GENDER DISTRIBUTION OF MEGALOBLASTIC ANEMIA
Sl.no. Sex No.of cases Percentage 
1 Male 16 47
2 Female 18 53
Total 34 100
Sex Incidence:
The incidence of Megaloblastic Anaemia is more or less same for men and 
women. Approximate male to female ratio is 1:1.1(chart-12).
TABLE 15
VITAL PARAMETERS IN CASES OF MEGALOBLASTIC ANAEMIA
ASSOCIATED WITH PANCYTOPENIA(n=34)
Parameter Range 
No.of 
patients
Hemoglobin(gm%)
1.8-5 12
5.1-8 14
8.1-9.0 8
Total 34
Total leukocyte Count 
(cells/mm3) 
500-1,000 3
1,001-2,500 7
2,501-3,900 24
Total 34
Reticulocyte Count(%)
<0.5 6
0.6-1 22
1.1-2 6
Total 34
Platelet  count (cells/mm3)
10,000-50,000 15
51,000-80,000 16
81,000-95,000 4
Total 34
Hemoglobin percentage:
Hemoglobin percentage varied from 1.8 % - 9.0g %. Half of the patients had 
Hemoglobin percentage between 5.1 – 8g %. While 12 patients had Hemoglobin
percentage between  1.8 – 5g%, 8 patients had Hemoglobin percentage between 8.1 –
9.0g %.
Total leukocyte count:
Total leukocyte count ranged from 500 – 3,900 cells/mm3 . While 7 patients 
had leukocyte count in the range 1,001 – 2,500 cells/mm3, 24 patients had white cell 
count in the range of 2,501 – 3,900 cells/mm3. Only 3 patients had white cell count in 
the range of 500 – 1,000.
Reticulocyte count:
Reticulocyte count ranged from 0.5 – 2 %. As much as 65% of the patients 
had Reticulocyte count between 0.6 – 1 %. Among the remaining 12 patients, 6 of 
them had the Reticulocyte count< 0.5 and the remaining 6 patients had the 
Reticulocyte count in the range 1.1 – 2. 
Platelet count:
Platelet  count varied from 10,000 – 95,000 cells/mm3. While 15 patients had 
their Platelet  count in the range 10,000 – 50,000 cells/mm3, an equal number of the 
patients had their Platelet  count in the range 51,000 – 80,000 cells/mm3. Only 4 
patients had white cell count in the range of 81,000 – 95,000(chart-13).
TABLE 16
RBC   MORPHOLOGY  IN MEGALOBLASTIC ANAEMIA 
Sl.No.           Blood picture No. of cases Percentage
1 Dimorphic anaemia 14 41
2 Macrocytic anaemia  11 32
3 Normocytic normochromic 7 21
4 Normocytic hypochromic 2 6
Total 34 100
           Majority of the cases ( 41 % ) showed Dimorphic anaemia, 32% of the patients showed 
Macrocytic anaemia. While 21 % of the cases showed Normocytic normochromic
anemia, 6 % showed Normocytic hypochromic anemia (chart-14).
TABLE 17
PERIPHERAL SMEAR PICTURE IN MEGALOBLASTIC ANEMIA
Sl.no Morphology No.of.patients Percentage 
1 Macrocytosis 34 100
2 Hypochromasia 22 65
3 Anisopoiklocytosis 34 100
4 Hypersegmentation of neutrophils 30 88
5 Leukoerythroblastosis 15 44
         While all the 34 patients had Macrocytosis and Anisopoiklocytosis, as much as 
88% had Hypersegmentation of neutrophils. Two-third of the patients had 
Hypochromasia (chart-15 & figure 4).
TABLE 18
INCIDENCE OF BONE MARROW HYPOPLASIA IN DIFFERENT
AGE GROUPS
Sl.no Age group 
(years)
No.of cases Percentage 
1 2--20 1 14
2 21-40 2 28
4 41-60 4 58
Total 7 100
Age Incidence:
Bone marrow hypoplasia showed its highest incidence ( 58%) in the age group 
41-60 followed by the age groups 21-40 ( 28%), and 2-20 (14 %) (chart-16). Figures 
7&8 depicts the bone marrow hypocellularity. 
TABLE  19
INCIDENCE OF BONE MARROW HYPOPLASIA IN BOTH GENDERS
Sl.no. Gender No.of cases Percentage 
1 Male 3 42
2 Female 4 58
Total 7 100
Sex Incidence:
         The incidence of Bone marrow hypoplasia is comparatively  higher in women 
than men, approximate male to female ratio being  2:3(chart-17).
TABLE 20
VITAL HAEMATOLOGICAL PARAMETERS IN BONE MARROW
HYPOPLASIA
Parameter Range No.of cases
Hemoglobin(gm%)
1.8-5 2
5.1-8 4
8.1-9.0 1
Total 7
Total leukocyte Count 
(cells/mm3) 
500-1,000 0
1,001-2,500 5
2,501-3,900 2
Total 7
Reticulocyte Count(%)
0.5 1
0.6-1 5
1.1-2 1
Total 7
Platelet  count (cells/mm3)
10,000-50,000 3
51,000-80,000 3
81,000-95,000 1
Total 7
Hemoglobin percentage:
Hemoglobin percentage varied from 1.8 % - 9.0g %. Half of the patients had 
Hemoglobin percentage between 5.1 – 8g %. While one-third of the patients had 
Hemoglobin percentage between 1.8 – 5g %, only one patient had Hemoglobin
percentage between 8.1 – 9.0g %.
Total leukocyte count:
Total leukocyte count ranged from 500 – 3,900 cells/mm3 . While three fourth 
of the patients had leukocyte count in the range 1,001 – 2,500 cells/mm3, one-fourth 
of the patients had white cell count in the range of 2,501 – 3,900 cells/mm3. None of 
the patients had white cell count in the range of 500 – 1,000cells/mm3.
Reticulocyte count:
Reticulocyte count ranged from 0.5 – 2 %. As much as 74% of the patients 
had reticulocyte count between 0.6 – 1 %. While 13 % of the  patients had the 
reticulocyte count 0.5 and the remaining 13 % of the patients had the reticulocyte
count in the range 1.1 – 2. 
Platelet  count:
Platelet  count varied from 10,000 – 95,000 cells/mm3. While 84% of the 
patients had their platelet  count in the range 10,000 – 50,000 cells/mm3 and 51,000 –
80,000 cells/mm3 each with 42%. Only 1 patient had platelet count in the range of 
81,000 – 95,000cells/mm3(chart-18).
TABLE 21
PERIPHERAL BLOOD PICTURE IN BONE MARROW HYPOPLASIA
Sl.No.           Blood picture No. of cases Percentage
1 Dimorphic anaemia 3 44
2 Macrocytic anaemia  1 12
3 Normocytic hypochromic 3 44
Total 7 100
          Among 7 cases 44% of the patient had dimorphic anemia, normocytic 
hypochromic anemia  in another 44% of the patients and macrocytic anemia in 12% 
of cases (chart-19).
TABLE 22
GRADE OF MYELOFIBROSIS AS SEEN BY RETICULIN STAIN
Sl.No. Grading No. of cases Percentage
1 Grade 0 10 20
2 Grade 1 14 28
3 Grade 2 22 44
4 Grade 3 4 8
5 Grade 4 0 0
Total 50 100
While 44 % of the patients had Grade 2, 28 % had Grade 1, 20 % had Grade 0, 
8 % had Grade 3. None of the patients had Grade 4 myelofibrosis (chart-20). Varying 
grades of myelofibrosis are demonstrated by reticulin stain is given in figures 17, 18 and 19.  
STATISTICAL ANALYSIS
TABLE 23
T-Test for vital hematological parameters and the clinical presentation
Values were tabulated in T-Test as above , which analysed the association 
between the vital hematological parameters and the clinical presentation .Results 
concluded the statistically significant relationship between the following:
1. TLC count and occurrence of Fever. 
2. Platelets count and occurrence of Bleeding.
3. Hb count and occurrence of Dyspnoea and Pallor.
4. TLC, platelets and Hb count and occurrence of Hepatomegaly.
5. TLC, platelets and Hb count and occurrence of Spleenomegaly.
Group Statistics
27 2916.67 746.402 143.645
23 2458.70 990.713 206.578
Fever
Negative
Positive
TLC (cells/mm3)
N Mean Std. Deviation
Std. Error
Mean
Independent Samples Test
4.125 .048 1.862 48 .069 457.971 246.004 -36.652 952.594
1.820 40.422 .076 457.971 251.611 -50.389 966.331
Equal variances
assumed
Equal variances
not assumed
TLC (cells/mm3)
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
TABLE 24
Correlation  of bone marrow study with the final diagnosis.
On the basis of the statistical significance values provided by the Chi-Square 
Tables, we arrive at the following conclusions:
1. The count of MA,AA ,MF ,ALL,AML ,MDS in the Final Diagnosis are 
statistically related  to the count of them in the Peripheral Smear.
2. The count of MA, AA, MF, ALL, AML, MDS in the Final Diagnosis are 
statistically related to the count of them in the Bone Marrow Aspiration ( BMA ).
3. The count of MA, AA, MF, ALL, AML, MDS in the Final Diagnosis are 
statistically related   to the count of them in the Bone Marrow Trephine( BMT).
        The above statistical findings establish the strong correlation between the 
peripheral blood findings with Bone Marrow Aspirate..
Chi-Square Tests
86.458a 15 .000
69.222 15 .000
50
Pearson Chi-Square
Likelihood Ratio
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
21 cells (87.5%) have expected count less than 5. The
minimum expected count is .04.
a. 
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ERYTHROID HYPERPLASIA
Figure 1:Bone marrow trephine biopsy showing
erythroid hyperplasia(100x in H&E).
Figure 2:Bone marrow trephine biopsy showing
erythroid hyperplasia(400x in H&E).
Figure 3: Bone marrow aspiration 
erythroid hyperplasia(400x in Leishman’s).
Figure 4:PS showing macroovalocytes and
hypersegmented neutrophil(1000x in Leishman’s).
showing
MEGALOBLASTIC ANEMIA
\Figure 5:Bonemarrow showing Megaloblast with Royalblue
cytoplasm and 
Figure 6:Bonemarrow showing Megaloblastic picture with 
dyserythropoesis(1000x in Leishman’s).
Inset showing giant metamyelocyte .
sieve like chromatin. (1000x in Leishman’s).
HYPOPLASTIC/
Figure 7
in 35yrs/M(Under 100x in Leishman’s)
Figure 8:Bone marrow showing increased fat to
APLASTIC ANEMIA
:Bone marrow showing Hypocellularity  
.
cell ratio (400x in Leishman’s)
Figure 9:Bone marrow showing 
Hypocellularity(1000x in Leishman’s).
MYELOFIBROSIS
Figure 10:Trephine biopsy showing stromal fibrosis 
streaming of cells and increased megakaryocytes.(400x in H&E).
Figure 11 :Case of myelofibrosis showing increased 
megakaryocytes(400x in H&E). 
SUBLEUKEMIC LEUKEMIA-ACUTE MYELOID LEUKEMIA
Figure 12:Peripheral smear showing Myeloblasts 
(400x in Leishman’s).Inset  showing  myeloblast.
SUBLEUKEMIC LEUKEMIA-ACUTE LYMPHOBLASTIC LEUKEMIA
Figure 13: Peripheral Smear showing small 
lymphoblasts(400x in Leishman’s).
Figure 14:Bone Marrow showing Lymphoblasts 
(1000x in Leishmans).
MYELODYSPLASTIC SYNDROME
Figure15:Bonemarrow showing dysplastic erythroblast with nuclear 
budding and binucleation.(400x in 
Figure 16:Bonemarrow showing dysplastic erythroblast with 
chromatin bridging.(1000x in Leishman’s).
                                 
Leishman’s). Inset showing 
erythroblast with cytoplasmic blebs.
RETICULIN STAIN PATTERN
Figure 17: Bonemarrow showing Grade 1 myelofibrosis with thin,
short reticulin fibres, but these do not intersect to 
form a network (400x ).
Figure 18:Bone marrow showing Grade 2 myelofibrosis with thin
reticulin fibres which intersect to form a network (400x).
Figure 19:Bonemarrow showing Grade 3 myelofibrosis thick and 
reduplicated reticulin fibres in the absence of collagen.(400x).
DISCUSSION
50 cases of pancytopenia during the period of March 2010 to August 2011 
were studied.
            Statistical data of age, sex, presenting complaints, various causes of
cytopenias, peripheral smear and bone marrow aspiration smears were studied, and
compared with those published in the literature.
TABLE 25
AGE, SEX DISTRIBUTION COMPARED TO OTHER STUDIES OF
PANCYTOPENIA
Sl.No. Authors No.of.cases Age range M : F
1 Khunger JM et al7 (2002) 200 2-70 1.2:1
2 Kumar R et al4 (2001) 166 12-73 2.1:1
3 Khodke K et al28 (2001) 50 3-69 1.3:1
4 Tilak V et al5 (1999) 77 5-70 1.14:1
5 Gayathri et al(2005) 104 2-80 1.2:1
6 Present study 50 2-60 1:1.2
           The age of the patients ranged from 2 years to 60 years with a mean age of 
39.5 years. Cytopenias were observed more in females (54 %) than males (46 %) with
a M:F ratio of 1:1.2 .
         In comparison to all other studies female predominance was noted in this study.
TABLE 26
PHYSICAL FINDINGS COMPARED TO OTHER STUDIES
A – Khunger JM et al 7 study(n=200), B – Tilak V et al5 study(n=77), C – Present Study(n=50).
           The most common presenting complaint in our study was generalized weakness 
(100%) and dyspnoea (46% ). The most common physical finding was pallor ( 86%)  
,followed by hepatomegaly ( 40% ) and splenomegaly ( 36% ).
       
         The presenting symptoms were usually attributed to anaemia, or thrombocytopenia. 
Leucopenia was an uncommon cause of the initial presentation of   the patient, but can 
become the most serious threat to life during course of the disorder. Physical findings were 
comparable with other studies.
Diseases Physical  Findings
Spleenomegaly Hepatomegaly Lymphadenopathy
A B C A B C A B C
Megaloblastic 
anemia
40 22 11 42 23 13 1 3 -
Aplastic anemia - 4 - 1 3 - - 1 -
Myelofibrosis - 2 5 - 1 5 - - -
Sub leukemic 
leukemia
8 1 1 10 - 1 6 - 1
MDS 4 - 1 4 - 1 - - -
TABLE 27
A comparison of the most common causes of pancytopenia in different studies:
Study group Country Year No. of 
cases
Commonest cause
IAASG Israel &
europe
1987 319 Hypoplastic  anemia
Keisu&Ost Israel 1990 100 Post radiation
Hossain et al Bangladesh 1992 50 Hypoplastic anemia
Verma &Dash India 1992 202 Hypoplastic  anemia
Tilak & Jain India 1999 77 Megaloblastic  anemia
Kumar et al India 1999 166 Hypoplastic  anemia
Khodke et al India 2000 50 Megaloblastic anemia
Bajracharya et al Nepal 2005 23 Hypoplastic anemia
Present study India 2010 50 Megaloblastic  anemia
IAASG-International Agranulocytosis and Aplastic Anemia Group
                
The commonest cause of pancytopenia, reported from various studies throughout 
the world has been aplastic anaemia5. This is in sharp contrast with the results  of various 
Indian  studies where the commonest cause of pancytopenia is megaloblastic anaemia2,4.7,28. 
Results observed in present study were also similar to those Indian studies. This seems to 
reflect the higher prevalence of nutritional anemia’s in Indian subjects.
TABLE 28
COMPARISON OF HAEMATOLOGICAL PARAMETERS IN MAJOR
SUBGROUPS OF CYTOPENIAS
Parameters
Aplastic anemia Megaloblastic anemia
A B A B
Hb g/dl 1.3-8 1.8-5 2.4-7 1.8-8
TLC×103/cumm 0.2-3.0 0.1-2.5 0.7-3.6 1-3.9
Platelets /cumm 8000-
86,000
10,000-
80,000
10,000-
1,30,000
10,000-80,000
A – Kumar R et al4 study (2001), B – Present study.
Haemoglobin, total leucocyte count and platelet count were comparable with other study.
Table 29 COMPARISON OF PERIPHERAL BLOOD FINDINGS WITH OTHER 
STUDIES.
Diseases
Total no of cases
anisopoiklocytos
is
Nucleated 
RBC
Hypersegmen
ted 
neutrophils
Immature 
WBC
reticulocy
tosis
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3
MA 53 144 34 51 140 34 13 18 7 45 - 30 - 18 - 5 - 2
AA 6 28 7 2 2 1 - - - 5 - - - - - 3 - -
MF 1 2 6 1 2 2 - 1 2 - - - - - - - - -
Sub LL 1 10 2 1 1 1 1 4 1 - - - 1 10 2 - - -
MDS - 4 1 - - 1 - 2 - - 1 1 - 3 - - - -
1-Tilak V et al(n=77),  2- Khunger JM et al(n=200)7,   3 – present study(n=50)
Hypersegmented neutrophils was noted in 88  % compared to 84.9% in Tilak V et.
al. study and  Khunger JM et al demonstrated no hypersegmented neutrophils in 
megaloblastic anaemia. In the present study of 50 cases,  23   cases had dimorphic anaemia,
macrocytic anaemia was found in 12   cases, normocytic normochromic and normocytic 
hypochromic anaemia constituted rest of the cases.
There are limited number of studies on the frequency of various causes of   
pancytopenia78.To the best of our knowledge ,limited data has been reported from Indian 
subcontinent . The variation in the frequency of various diagnostics entities causing  
pancytopenia has been attributed to differences in methodology and stringency of 
diagnostics criteria , geographic area ,period of observation , genetic differences  and 
varying exposure  to myelotoxic agents etc79.
The incidence of megaloblastic anaemia varied from   0.8 to 32.26% of all
pancytopenic patients5. Our incidence of megloblastic anaemia was 68  %. Incidence of
72% was reported by Khunger JM et al and 68% by Tilak V et al. All the above studies 
done in India, stress the importance of megaloblastic anaemia being the major cause of 
pancytopenia. It is a rapidly correctable disorder and should be promptly notified7.
Bone marrow aspiration showed megaloblastic erythroid hyperplasia (fig1&2).
Although bone marrow aspiration study is uncommon in a suspected megaloblastic 
anaemia, if the diagnosis does not appear straight forward or if the patient requires urgent
treatment and haematological assays are not available, bone marrow aspiration is indicated
(fig 3). As facilities for estimating folic acid and vitamin B12 levels are not routinely 
available in most centers in India, the exact deficiency is usually not identified4. Figures 
5 & 6 depicts the bone marrow picture of megaloblastic dyserythropoesis. 
    Incidence of aplastic anaemia varies from  10-52 % among pancytopenic Patients7.
Our incidence of hypoplastic anaemia was 14 %, which correlated with the studies done by 
Khodke K et al and Khunger JM et al whose incidence for the same was 14%7, 28. A higher 
incidence of 29.5% was reported by Kumar R et al4. Most of the cases of aplastic anaemia 
were idiopathic (fig9).
Dyserythropoiesis was the feature in few cases. Aplastic/hypoplastic anaemia/bone 
marrow failure can be inherited or acquired and can involve just one cell line or all the
three cell lines. Hypoplastic MDS is a differential diagnosis of aplastic anaemia. But the
presence of blasts indicates the diagnosis of hypoplastic MDS24(fig15&16). 
The incidence of aplastic anaemia quoted from the west is much higher than that 
observed by us. This increased incidence may be related to environmental factor such as
increased exposure to toxic chemicals28.
We encountered   4 %  of subleukemic leukemia compared to Khunger JM et al who 
has reported 5% of subleukemic leukemia, Kumar R et al reported 12% of aleukemic 
leukemia.  Pancytopenia was the common feature of subleukemic leukemia in our study, 
this correlated with Kumar R et al, Gayathri et al and Khunger JM et al studies4,7. The 
diagnosis of acute leukemias was based on bone marrow aspiration study, and we reported 
1 case of AML-M2 (fig12) and 1 case  of ALL –L2 (fig13&14). Khodke K et al reported a 
single case of AML-M2 of 50 cases of pancytopenia. Kumar R et al reported 5 cases of
ALL, 13 cases of AML, 2 cases of hairy cell leukemia out of 166 cases of pancytopenia, 
over a 6 year study period4,28.
     Pancytopenia with few abnormal cells as seen in MDS was seen 2% of cases. 
Hypercellularity of the marrow with the abnormal cells confirmed the diagnosis. 
Myelodysplastic syndrome is a disease characterized by ineffective erythropoesis. It differs  
from AML  by its early apoptosis in early and mature  hematopoetic cells.MDS, may thus 
be suspected in various cases of pancytopenia as also revealed in various other Indian 
studies80. Same 2%wasalso noted by Khunger et al.
           Myelofibrosis was seen in 2% of our cases of pancytopenia (fig10&11). Literature 
also reveals pancytopenia in  cases of myelofibrosis by keiss et al81 and khunger et al.
Megaloblastic Anaemia was observed to be the commonest cause of Pancytopenia  
in this study. This fact indicates the acute Vitamin B12 and folate deficiency. If this 
nutritional deficiency, which is widely prevalent now in this region, is set right, the number 
of Pancytopenia cases reported in the Hospitals will no doubt get drastically reduced.
SUMMARY
This is a prospective Clinico-Hematological study on Pancytopenia over a 
period of  18months from March 2010 to August 2011 in the Haematology Unit, 
Department of Pathology, Coimbatore Medical College, Coimbatore.
50 patients in age group between 2-60 yrs  presenting with cytopenias were 
evaluated.
A combined evaluation of physical findings, primary haematological
investigations and bone marrow aspiration were done in cytopenic patients.
The age of the patients ranged from 2 years to 60 years with a mean age of 39.5
years. Males accounted for 23 cases ( 46 %)  and female  27 cases ( 54  %) with
a M:F ratio of     1:1.2.     
Commonest presenting complaint was generalised weakness and fever.
Commonest physical finding was pallor followed by hepatomegaly and
splenomegaly.
Megaloblastic anemia ( 68 % ) was the commonest cause of cytopenia followed 
by hypoplastic /aplastic anemia( 14 % ), myelofibrosis ( 12 %), subleukemic 
leukemia (  4 % ) and MDS(  2 % ).
Lowest haemoglobin percentage was 1.8 gm/dl and noted in a case of                     
megaloblastic anaemia.
Lowest total leucocyte count was 500 cells/mm3 and noted in a case of                    
megaloblastic anaemia.
Lowest platelet count of 20,000 cells/mm3 was noted in a case of megaloblastic  
anaemia.
Dimorphic anaemia was predominant blood picture in cytopenic patients
Hypercellular marrow was noted in 38 patients and the common cause was
megaloblastic anaemia, followed by leukemia,myelofibrosis, MDS.
Hypocellular marrow was noted in 11  patients and commonest cause was
                    hypoplastic/aplastic anaemia. 
Grading of associated marrow fibrosis by reticulin stain showed the predominance 
of grade 2 observed in 22 cases.   
.
CONCLUSION
                  
Pancytopenia is not an uncommon haematological problem encountered in
clinical practice and should be suspected on clinical grounds when a patient presents
with unexplained anaemia, prolonged fever and tendency to bleed.
The physical findings and peripheral blood picture provides valuable
information in the work of cytopenic patients.
Evaluation of peripheral blood film reveals the most probable cause of
anaemia, presence of nucleated RBC’s and/or immature myeloid cells may suggest
marrow infiltration or primary haematologic disorder.
Bone marrow aspiration is an important diagnostic tool in haematology which
helps to evaluate various cases of cytopenia. Bone marrow examination is an accurate, 
reproducible, rapidly available information at an economical cost and with minimal 
discomfort to the patient. Bone marrow aspiration is sufficient to make a diagnosis in 
cases of nutritional anaemias and initial diagnosis of leukemia.
Megaloblastic anaemia was the commonest cause which indicates the high
prevalence of nutritional anaemia in our region.
The other common causes were hypoplastic/aplastic marrow. However,
uncommon and rare causes such as multiple myeloma, storage disease should be kept
in mind while planning investigation for complete work up of cytopenic patients.
In patients presenting with cytopenia and hepatosplenomegaly, smear revealed 
dimorphic picture , but marrow showed megaloblastic change indicating acute 
vitamin B12 and folate deficiency in patients.
       Tuberculosis being highly prevalent and endemic in India, it is essential to be
aware of its manifestation as pancytopenia.
                     Present study concludes that detailed primary haematological 
investigations along with bone marrow examination in cytopenic patients is helpful 
for understanding of the disease process, to diagnose or to rule out the causes of 
cytopenia and helpful in planning further investigations and management of cytopenic 
patients.
ANNEXURE 1
PROFORMA
COIMBATORE MEDICAL COLLEGE
DEPARTMENT OF PATHOLOGY
COIMBATORE
Particulars of the patient :
Name :                        Hospital:
Case No:                       Date :
Age/sex :                       I.P No. :
Address :                       Ward No. :
Occupation                     Religion :
Presenting complaints and duration :
Weakness / Dyspnoea / Palpitation / Guiddiness / Angina + / -
Fever / Sweats / Infection + / -
Purpura / Ecchymosis / Bleeding diathesis / Skin infections / parasthesia + / -
Past history :
Previous history of anemia
Transfusions + / -, Drugs + / -, Liver disease + / -, Chronic diseases + / -,
Exposure to radiation + / - chemicals + / -.
Family history :
Anemia + / -, Bleeding diathesis + / -, Malignancy + / -, Recurrent jaundice + / -.
Personal history :
Diet : Appetite : Bowel / Bladder habits :
Sleep : Alcohol intake : Smoking :
Menstrual history:
General physical examination :
Built :  Nourishment :  Conscious :   Weight
Pulse :    RR :   BP:         Febrile / Afebrile :
Pallor :    Jaundice :        Cyanosis :         Clubbing :
Lymphadenopathy :        Edema :          Mouth :          Skin :
Systemic examination :
P/A :       Hepatomegaly :         Splenomegaly :      Ascites :
CVS :   RS :    CNS :      Musculo-skeletal-bone pain:s + / -
Clinical diagnosis :
Investigations : 
1.Complete haemogram(autoanalyser)
Sl. No.        Tests                  Observed Value
i.           Hb%
ii.           RBC count.
iii.           WBC count.
iv.           Platelet count.
v.           PCV.
vi.           MCV.
vii.           MCH.
viii.           MCHC.
2.                 Retic count.
2.Peripheral smear :
RBC :
WBC :
Platelets :
Parasites :
Impression :
3.Bone marrow study (Bone marrow aspiration No.)
Aspirate :
Cellularity :
Myeloid : erythroid ratio :
Erythropoiesis
Leucopoiesis :
Megakaryopoiesis :
4. Bone marrow trephine (Hpe no.)
Cellularity :
Architecture:
Presence of fibrosis:
Focal lesions:
5.RETICULIN STAIN:
Grading of fibrosis.
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1 480/10 11029 54 M + + - - + - - - 2 1800 42,000 MA Hypo
cellular
Hypo
plastic
0 AA
2 686/10 18953 55 M + - - - + - - - 8 3800 95,000 NN MB EH 2 MA
3 730/10 21231 24 M + + + - + + + - 1.8 500 40,000 MA MB EH 2 MA
4 909/10 25670 43 M + + + - + + + - 6.8 2100 70,000 DA MB EH 0 MA
5 1047/10 26372 38 F + + - - + - - - 2.4 1600 25,000 NH Hypo cellular Hypo plastic 1 AA
6 1082/10 30590 42 F + + + - + - - - 8 3800 90,000 NN MB EH 1 MA
7 1086/10 30032 45 F + + + - + + - - 7 1600 20,000 DA MB EH 1 MA
8 117410 33274 15 F + + - - + + + - 3.4 1600 60,000 DA MB EH 1 MA
9 1288/10 35009 58 F + - - - - + + - 6.2 3300 77,000 LEB DRY Hypo cellular 3 MF
10 1289/10 34945 28 F + + - - + - - - 2.5 1000 34,000 MA MB EH 2 MA
11 1439/10 37013 60 F + - - - - - - - 5.6 2300 43,000 DA Hypo cellular Hypo plastic 0 AA
12 1470/10 39528 10 F + - - - - - - - 4.2 2600 49,000 MH Hypo cellular Hypo plastic 1 AA
13 1563/10 41420 40 M + - + - + - - - 8.5 3600 64,000 NN MB EH 1 MA
14 1574/10 39628 15 F + - - - + - - - 7.6 3600 90,000 MA MB EH 1 MA
15 1645/10 42922 48 F + - - - + - + - 2.4 2600 46,000 MA MB EH 2 MA
16 1648/10 45224 47 M + + + - + - - - 4.2 2900 57,000 DA MB EH 2 MA
17 1668/10 17107 60 M + + - - + - - - 6.6 3500 62,000 NH MB EH 1 MA
18 1972/10 53257 58 M + - + - + - - - 4.2 2900 47,000 LEB DRY Hypo cellular 3 MF
19 2049/10 55156 50 F + + - - + - - - 3.6 3800 54,000 DA MB EH 2 MA
20 2112/10 58445 50 M + + - - + + + - 8.2 2900 44,000 DA MB EH 1 MA
21 2151/10 58996 16 F + + + - + - - + 5.3 3300 29,000 SLL ALL-L2 Infil -trative 0 ALL-L2
22 2157/10 59821 20 M + + + - + - - - 5.8 2600 49,000 MA MB EH 2 MA
23 G400/10 11818 27 F + - - - + - - - 6.2 3200 68,000 MA MB EH 2 MA
24 G394/10 11014 23 F + + + - + + + - 6.8 3400 66,000 DA MB EH 2 MA
25 2361/10 65496 16 F + - + - + + + - 4.5 3500 72000 DA DRY Hypo cellular 3 MF
26 2368/10 63825 5 F + - + - + - - - 8.8 1900 56,000 NN MB EH 0 MA
27 2369/10 63597 46 M + - - - + + + - 7.6 2800 72,000 DA MB EH 2 MA
28 2419/10 66875 52 F + - + - + + - - 6.8 2100 46,000 NN MB EH 0 MA
29 2491/10 69509 28 F + - + - + - - - 9 3900 67,000 NN MB EH 2 MA
30 2604/10 69461 29 M + - - - + - - - 6.4 3200 18,000 MA MB EH 2 MA
31 2605/10 71211 50 F + - - - + + + - 2.6 650 20,000 MA MB EH 2 MA
32 2653/10 73500 41 F + + + - + - - - 6 2200 55,000 DA Hypo cellular Hypo plastic 1 AA
33 2654/10 71577 40 F + - + + + + + - 2.4 3300 33,000 MA MB Normal 1 MA
34 2660/10 73345 23 M + + + - + - - - 8.6 1250 73,000 NH MB EH 0 MA
35 2707/10 73337 57 F + + + - + - + - 2.8 2700 69000 DA MB EH 2 MA
36 109/11 1727 46 M + - - - - + - - 4.3 2300 43000 NH Hypo cellular Hypo plastic 1 AA
37 404/11 9961 58 M + + + - + + + - 7.6 3400 46,000 DA MB EH 2 MA
38 642/11 14972 23 M + + - - + - - - 3.6 3300 39,000 MA MB EH 2 MA
39 676/11 16125 50 M + - - - - + + - 4.2 3800 64,000 DA Normal Hyper cellular 2 MF
40 854/11 22713 55 F + - + - + - - - 4.6 2800 52,000 MA MB EH 0 MA
41 875/11 21836 55 F + - + - + + + - 5.2 3600 60,000 SLL AML Infil- trative 1 AML-M2
42 886/11 20489 5 F + + - - + - - - 5.6 3500 49,000 DA MB EH 2 MA
43 942/11 24896 33 M + - + - + + + - 6.4 2200 70,000 NN MB EH 0 MDS
44 1008/11 26251 41 M + - - - + - - - 4.2 2600 57,000 DA MB EH 2 MA
45 1346/11 36024 58 M + - - - + - - - 6.2 2100 65,000 DA MB Hyper cellular 2 MA
46 1347/11 34528 28 M + + - - + - - - 2.3 1100 40,000 DA Hypo cellular Hypo plastic 0 AA
47 1397/11 36043 45 F + + + - + + - - 8.6 2700 54,000 NN MB EH 2 MA
48 1401/11 35433 55 F + - - - - + + - 7.2 3200 34,000 NN Normal Hyper cellular 2 MF
49 1475/11 38453 41 M + - - - - + + - 6.3 3500 62,000 LEB DRY Hypo cellular 3 MF
50 1663/11 40111 60 M + - - - + - - - 7.2 3400 75,000 DA MB EH 1 MA
KEY TO MASTER CHART
MA-Macrocytic anaemia
AA-Aplastic anemia
MB-Megaloblastic anemia
DA-Dimorphic anemia
NN-Normocytic Normochromic
LEB-Leukoerythroblastic picture
NH-Normocytic Hypochromic
MF-Myelofibrosis
MDS- Myelo Dysplastic Syndrome
AML-M2-Acute Myeloid Leukemia (M2 type)
ALL-L2-Acute Lymphoblastic Leukemia (L2 type)
Hb(g%)-Hemoglobin
TLC- Total leukocyte count.
SLL – Subleukemic leukemia
ANNEXURE 3
NORMAL REFERENCE VALUES
TABLE. 1 : HAEMATOLOGY REFERENCE VALUES IN NORMAL ADULTS29
TEST MEN WOMEN
Hemoglobin 14-17g/dl 12.3-15.3g/dl
Hematocrit 41.5-50.4% 36-45%
Red cell count 4.5-5.9×106/µl 4.5-5.1×106/µl
White cell count 4.4 -11.3×103/µl 4.4 - 11.3×103/µl
MCV 80 - 96 fl 80 - 96 fl
MCH 27.5 - 33.2pg 27.5 – 33.2pg
MCHC 33.4 - 35.5g/dl 33.4 - 35.5g/dl
Platelet count 150-450×103/µl 150-450×103/µl
Reticulocyte count 0.5-2.5% 0.5-2.5%
ESR 0-15mm/hr 0-20mm/hr
TABLE. 2 : DIFFERENTIAL COUNTS OF BONE MARROW ASPIRATE29
OBSERVED 
RANGE(%)
MEAN(%)
NEUTROPHILIC 
SERIES(TOTAL)
49.2-65 53.6
Myeloblasts 0.2-1.5 0.9
Promyelocyte 2.1-4.1 3.3
Myelocyte 8.2-15.7 12.7
Metamyelocyte 9.6-24.6 15.9
Band 9.5-15.3 12.4
Segmented 6.0-12.0 7.4
EOSINOPHILIC SERIES(TOTAL) 1.2-5.3 3.1
Myelocyte 0.2-1.3 0.8
Metamyelocyte 0.4-2.2 1.2
Band 0.2-2.4 0.9
Segmented 0-1.3 0.5
BASOPHILIC AND MAST 
CELLS
0-0.2 <0.1
ERYTHROID SERIES(TOTAL) 18.4-33.8 25.6
Pronormoblast 0.2-1.3 0.6
Basophilic 0.5-2.4 1.4
Polychromatophilic 17.9-29.2 21.6
Orthochromatic 0.4-4.6 2.0
LYMPHOCYTE 11.1-23.2 16.2
PLASMA CELLS 0.4-3.9 1.3
MONOCYTE 0-0.8 0.3
MEGAKARYOCYTE 0-0.4 <0.1
RETICULUM CELLS 0-0.9 0.3
Myeloid : Erythroid 1.5-3.3 2.3
TABLE 3 :AUTOANALYSER REFERENCE RANGES39:
PARAMETERS RANGE FOR FEMALES RANGE FOR MALES
WBC(per µL) 3.1-10.3 2.6-8.8
RBC(per µL) 3.2-4.6 3.6-5.3
Hg(g/dl) 9.9-13.6 11.3-15.7
HCT(%) 30.2-42.3 32.6-47.5
MCV(fl) 78.6-102.2 80.3-103.4
MCH(pg) 25.2-34.7 26-34.4
MCHC(g/dl) 31.3-35.4 31.8-36.3
Plt(per µL) 128-434 134-377
Lym% 15-45.8 17.5-47.9
Mxd% 1.3-25.9 1.9-24.6
Neut% 43.7-77.1 38.3-69
Lym#(per µL) 0.9-2.8 0.8-2.7
Mxd#(per µL) 0.1-1.6 0.1-1.5
Neut#(per µL) 1.6-6.9 1.2-5.3
RDW-CV(%) 10.6-15.7 10.8-14.9
RDW-SD(fl) 35.3-48.9 33.4-49.2
PDW(fl) 9.4-18.1 9.8-18.0
MPV(fl) 8.5-12.4 8.1-12.4
P-LCR(%) 14.3-44 10.7-45.0
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